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responsive PKC isozymes are also activated by phorbol1Laboratory of Molecular Biology
esters, which are potent agonists that bind to the sameNational Institute of Diabetes and Digestive
site as diacylglycerol. These PKC isozymes are acti-and Kidney Diseases
vated by diacylglycerol and phorbol esters by virtue ofNational Institutes of Health
their direct binding to motifs known as protein kinaseU.S. Department of Health and Human Services
C homology-1 (C1) domains (Hurley et al., 1997; NewtonBethesda, Maryland 20892
and Johnson, 1998; Nishizuka, 1992, 1995; Ono et al.,2 Department of Pharmacology and Center for
1989; Ron and Kazanietz, 1999).Experimental Therapeutics
In recent years, it has become clear that there areUniversity of Pennsylvania School of Medicine
several major classes of C1 domain-containing diacyl-Philadelphia, Pennsylvania 19104
glycerol receptors in addition to PKC. Munc-13 proteins
are phorbol ester binding scaffolding proteins involved
in Ca2-stimulated exocytosis (Betz et al., 1998; BroseSummary
and Rosenmund, 2002; Rhee et al., 2002). RasGRPs are
diacylglycerol-activated guanine-nucleotide exchangeThe lipid second messenger diacylglycerol acts by
factors (GEFs) for Ras and Rap1 (Ebinu et al., 1998;binding to the C1 domains of target proteins, which
Tognon et al., 1998). The - and -chimaerins are atranslocate to cell membranes and are allosterically
family of phorbol ester- and diacylglycerol-responsiveactivated. Here we report the crystal structure at 3.2 A˚
GTPase-activating proteins (Ahmed et al., 1990, 1993;resolution of one such protein,2-chimaerin, a GTPase-
Areces et al., 1994; Caloca et al., 1997, 1999; Hall et al.,activating protein for the small GTPase Rac, in its in-
1990; Leung et al., 1994).active conformation. The structure shows that in the
In vitro studies using recombinant chimaerin isoformsinactive state, the N terminus of 2-chimaerin pro-
show that, like PKCs, they bind phorbol esters with lowtrudes into the active site of the RacGAP domain, steri-
nanomolar affinity in the presence of acidic phospholip-cally blocking Rac binding. The diacylglycerol and
ids (Areces et al., 1994; Caloca et al., 1997).1-chimaerinphospholipid membrane binding site on the C1 domain
(formerly known as n-chimaerin) and 2-chimaerin areis buried by contacts with the four different regions
alternatively spliced products of a single gene, as areof2-chimaerin: the N terminus, SH2 domain, RacGAP
1- and 2-chimaerin. 2-chimaerin contains three con-domain, and the linker between the SH2 and C1 do-
served domains. The N-terminal Src homology-2 (SH2)mains. Phospholipid binding to the C1 domain triggers
domain is presumed competent to bind phosphotyro-the cooperative dissociation of these interactions,
sine-containing proteins, but its physiological partnerallowing the N terminus to move out of the active site
is unknown. The central C1 domain is followed by aand thereby activating the enzyme.
C-terminal GAP domain with homology to many other
Rho, Rac, and Cdc42 GAPs. The GAP activity of 2-Introduction
chimaerin is specific for Rac as opposed to other small
G proteins (Caloca et al., 2003). Rac is a member of the
Diacylglycerol is a paradigmatic lipid second messenger
Rho small GTP binding protein (G protein) family that
in metazoan cell signaling, the first to be discovered
also includes Rho and Cdc42 isoforms. These small G
(Kikkawa et al., 1989; Nishizuka, 1988, 1992, 1995). Diac- proteins regulate actin dynamics, transcription, the cell
ylglycerol is a central mediator of downstream signaling cycle, cell adhesion, and many other cell processes
by a host of hormones coupled through Gq and phospho- (Bishop and Hall, 2000). The proper function of GAPs in
lipase C-, growth factors coupled to tyrosine kinase- cell regulation is vitally important since failure to appro-
linked receptors and phospholipase C-, and many priately inactivate small G proteins is associated with
other extra- and intracellular stimuli (Nishizuka, 1995). cancer (Bishop and Hall, 2000). Indeed, downregulation
The protein kinase C (PKC) isozyme family has histori- of 2-chimaerin has been found in some types of can-
cally been the most intensively studied class of targets cers such as high-grade gliomas, and the reduced ex-
for diacylglycerol signaling (Kikkawa et al., 1989; Mellor pression of this gene may contribute to the development
and Parker, 1998; Newton and Johnson, 1998; Nishi- of the tumor (Yuan et al., 1995).
zuka, 1988, 1992, 1995; Ron and Kazanietz, 1999). In C1 domains are compact zinc fingers of 50–51 amino
acids. Their structure comprises two small  sheets and
*Correspondence: hurley@helix.nih.gov a single helix folded around two Zn2 ions (Hommel et
3These authors contributed equally to this work. al., 1994; Hurley and Misra, 2000; Hurley et al., 1997;
4Present address: Prolexys Pharmaceuticals, Salt Lake City, Utah
Zhang et al., 1995). The two strands in the smaller 84116.
sheet are pulled apart, due to a break in their hydrogen5Present address: Department of Nephrology, Medizinische Hoch-
bonding induced by a conserved Pro residue. Phorbolschule Hannover and Mosaiques Diagnostics AG, Feodor-Lynen Str.
21, 30625 Hannover, Germany. ester binds stereospecifically in the groove formed
Cell
408
where the two strands pull away from each other. The et al., 1997b) is 1.5 A˚. The most notable feature of the
SH2 domain is that the C-terminal (B) helix is longer,stereospecific phorbol ester binding site is surrounded
on three sides by bulky hydrophobic side chains, which five turns as compared to three in Src and its relatives
(Sicheri et al., 1997; Xu et al., 1997b), and the helix is inform a hydrophobic wall around the phorbol ester bind-
ing site (Zhang et al., 1995). Distal to the phorbol ester a different orientation (Figure 1C). The final strand, G,
which follows the B helix in canonical SH2 domains,binding site, Arg, Lys, and His residues form a basic
belt on the surface of the C1 domain. The hydrophobic is absent. The SH2 domain resembles that of the APS
adaptor protein, which also has a long B helix andwall inserts in the hydrocarbon core of phospholipid
bilayers upon binding, while the basic belt interacts with lacks the G strand (Hu et al., 2003). The side chains of
Arg64, Arg81, and Arg104, and the main chain NH groupacidic phospholipid headgroups (Xu et al., 1997a). The
high affinity of C1 domain/phorbol ester interactions in of Gln84 together form an apparent pocket for phospho-
tyrosine binding. However, in the uncomplexed struc-the presence of bilayers or micelles is due to the syner-
gism between the stereospecific phorbol ester binding ture observed here, the side chain of Arg64 is rotated
away from the phosphotyrosine binding site.and nonspecific binding of acidic phospholipids to the
basic and hydrophobic exterior surface of the C1 domain
(Kazanietz et al., 1995a). Translocation and activation C1 Domain
of C1 domain proteins requires the interplay of specific The C1 domain is at the heart of the tertiary structure
and nonspecific activators: both diacylglycerol or phor- of 2-chimaerin. The C1 domain is closely superimpos-
bol ester and bulk phospholipid. able on the C1B domain of PKC-, with an rmsd (all C
Structural and functional studies of C1 domains have positions) of 0.8 A˚ (Figure 1D). The C1 domain makes
established the mechanism for diacylglycerol and phor- extensive contacts with the N terminus, both the SH2
bol ester-induced translocation to membranes (re- and RacGAP domains, and with interdomain linkers. The
viewed in Hurley and Meyer [2001]; Hurley and Misra C1 domain has a total of 4056 A˚2 of solvent-accessible
[2000]; Newton and Johnson [1998]). Concomitant with surface area in isolation; this is reduced to 2481 A˚2 in
membrane translocation, PKCs, chimaerins, and other intact2-chimaerin. The putative membrane binding ba-
C1 domain proteins become allosterically activated. The sic residues on the C1 surface (Lys216, His218, Arg221,
PKC activation mechanism is thought to require a large His224, Arg242, and Lys252) are solvent exposed. The
conformational change, on the basis of changes in sus- putative membrane binding hydrophobic residues
ceptibility to limited proteolysis (Orr et al., 1992; Orr Pro223, Trp225, Phe232, and Trp234 are completely bur-
and Newton, 1994), translocation kinetics (Oancea and ied in intramolecular contacts with the rest of 2-chi-
Meyer, 1998), fluorescence (Slater et al., 1999), surface maerin (Figure 2A). Leu236 and Ile237 are partially buried
pressure analysis (Medkova and Cho, 1999), and other in contacts with the SH2 domain. The polar surface of
indirect structural techniques. In the absence of direct the C1 domain is for the most part solvent exposed.
structural information on an intact C1 domain-con- Among the exceptions is Asn231, which forms a hydro-
taining protein, the nature of such conformational gen bond with Tyr141 of the SH2-C1 linker. Tyr228 forms
changes has been elusive. Here we report the crystal hydrophobic contacts with Pro149 and Tyr151 of the
structure of full-length 2-chimaerin and deduce a SH2-C1 linker.
mechanism for its allosteric activation by lipids.
RacGAP Domain
Results The RacGAP domain is homologous to the structurally
characterized RhoGAP domains of p120GAP (Scheffzek
2-chimaerin was expressed as a recombinant protein et al., 1996), PI 3-kinase p85 subunit (Musacchio et al.,
using the baculovirus/Sf9 cell system, purified, and crys- 1996), p50RhoGAP (Rittinger et al., 1997a; Rittinger et
tallized. The structure of 2-chimaerin was determined al., 1997b), and Cdc42GAP (Nassar et al., 1998). The
by single anomalous dispersion from the two native Zn2 structures are similar, as expected from sequence simi-
ions and a single Xe atom, in combination with molecular larity (Figure 1E). The RacGAP domain of 2-chimaerin
replacement, using the SH2 domain of Src (Xu et al., can be superimposed on the RhoGAP domains of
1997b), the C1B domain of PKC (Zhang et al., 1995), p50RhoGAP (Rittinger et al., 1997b) and Cdc42GAP
and the RhoGAP domain of Cdc42GAP (Nassar et al., (Nassar et al., 1998) with rmsd values of 1.2 A˚ for both.
1998) as probes. The structure has been refined to an The 2-chimaerin RacGAP domain structure has no ma-
R factor of 0.25 at a resolution of 3.18 A˚ (Table 1). The jor differences with the unliganded structure of the Rho-
entire sequence can be visualized in the electron density GAP domain of p50RhoGAP (Barrett et al., 1997). The
(Figure 1A), with the exception of the first 20 residues largest change between the 2-chimaerin RacGAP do-
and residues 162–208 from the SH2-C1 domain linker. main and the RhoGAP domain in the p50RhoGAP/RhoA-
The domains are arranged with the C1 domain in the GDP·AlFx complex structure of RhoGAP domains (Rit-
middle and the RacGAP and SH2 domains on either side tinger et al., 1997b) is seen in the F helix, which moves
(Figure 1B). The overall dimensions of the structure are 6 A˚ to bind to the small G protein in the bound form
85  55  40 A˚. (Figure 1E).
No experimental structure of the RacGDP·AlFx com-
plex with 2-chimaerin is available, so this structure wasSH2 Domain
The SH2 domain is superimposable on the structures modeled by superimposing the RhoGAP domain of the
p50RhoGAP/RhoA-GDP·AlFx complex on the 2-chi-of other such domains. The rmsd (for C positions, ex-
cluding the last helix) versus the SH2 domain of Src (Xu maerin RacGAP domain. The structure of RacGDP·AlFx
Lipid Activation of 2-Chimaerin
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Table 1. Crystallographic Data Collection, Phasing, and Refinement Statistics
(A) Crystallographic Data and Phasing Statistics
Space group: P6122
Cell dimensions (A˚), native: a 	 b 	 131.28, c 	 289.04,  	  	 90
,  	 120

Cell dimensions (A˚), xenon derivative: a 	 b 	 131.07, c 	 284.70,  	  	 90
,  	 120

dmin (A˚) No. of reflections Completeness (%)a I/a Rsym (%)a,b
Native ( 	 1.1 A˚) 3.2 109,671 99.5 (98.8) 27.0 (3.3) 5.8 (58.0)
Xenon ( 	 1.28 A˚) 3.8 244,997 95.0 (69.1) 34.5 (3.8) 7.9 (49.6)
Phasing
Bijvoet ratioc, Xe,  	 1.28: 4.5%
Figure of merit: 0.29 (0.66)d
Phasing power: 1.30
(B) Refinement
Resolution range 20.0 – 3.2 A˚
Number of reflections 23,767
Rworkinge 24.8%
Rfreef 29.0%
Bond-length deviation 0.008 A˚
Bond-angle deviation 1.56

Average B factor 93.4 A˚2
a Values in parentheses are for the highest resolution bin.
b Rsym 	 hi|Ii(h)  I(h)|/hiIi(h)
c Ratio is calculated as |F|/|F|.
d Value in parentheses is the figure of merit after solvent flattening.
e R 	 (|Fobs|  k|Fcalc|)/|Fobs|.
f Rfree is the R value calculated for a test set of reflections, comprising a randomly selected 5% of the data that is not used during refinement.
as observed in complex with the GAP domain of Pseu- domain. This L helix is in contact with and antiparallel
to the N helix.domonas aeruginosa ExoS protein was then superim-
posed on the RhoA portion of the p50RhoGAP/RhoA-
Mutational Analysis of 2-ChimaerinGDP·AlFx structure (Wurtele et al., 2001). The modeled
Translocation and RacGAP Activity2-chimaerin/Rac complex places Arg311 of 2-chi-
In order to test the role of intramolecular contactsmaerin within 1.9 A˚ of the nearest F ion in the
between various domains of 2-chimaerin and the C1RacGDP·AlFx complex (Figure 3). Most contacts be-
domain, we constructed and characterized ten site-tween p50RhoGAP and RhoA on the one hand, and 2-
directed mutants of internal contact residues. Thesechimaerin and Rac on the other, are conserved. The
residues were selected from positions of the N and Lonly major exception is in the RacGAP A helix. Phe315
helices, and the SH2 and RacGAP domains that contactand Glu317 of 2-chimaerin interact with Ala88 and
the C1 domain (Figure 4A). These mutants were de-Ala95 of Rac. In Rho, these two Ala are replaced by
signed to destabilize the inactive conformation, therebyAsp90 and Glu97, while in p50RhoGAP the Phe and Glu
lowering the free energy required to reach the activeof the RacGAP domain are replaced by Asn and Gln. In
state. To assess the responsiveness to C1 domain ligandanother difference, part of the Rac interaction surface
binding in a cellular context, we quantitated the translo-on the RacGAP domain is occluded by Pro21 and Pro22
cation of2-chimaerin in COS-1 cells. Our previous workof the N terminus of 2-chimaerin.
had shown that 2-chimaerin required a higher concen-
tration of phorbol ester for translocation compared to
N-Terminal and Linker Regions phorbol ester-responsive PKCs (Caloca et al., 1997,
The ordered part of the N-terminal region of 2-chi- 1999). All but one of the mutants were sensitized to
maerin (residues 21–54) extends 60 A˚, essentially the phorbol ester-induced translocation. Remarkably, mu-
entire length of the protein (Figure 1F). The segment tants Q32A-2-chimaerin and I130A-2-chimaerin are
comprising residues 21–24 is in contact with the Rac- highly sensitive to PMA-induced translocation, as judged
GAP domain. Residues 27–34 form a helix (N) that rests by the significantly lower EC50 observed for the phorbol
against the membrane binding site and covers the phor- ester effect (Figures 4B and 4C). This last mutant was
bol ester binding groove of the C1 domain. Gln32 of the almost as sensitive as PKC for PMA-induced transloca-
N terminus protrudes into the phorbol ester binding site tion. In order to determine whether the mutants had
and forms hydrogen bonds with the unpaired  strand enhanced RacGAP activity in vivo, we directly measured
at Gly235 (Figures 2C and 2D). The remaining residues Rac-GTP levels in vivo using a p21 binding domain pull-
of the N terminus (35–54) form an extended loop reach- down assay (Benard et al., 1999). While transfection
ing to the start of the SH2 domain. Of the first 25 of wild-type 2-chimaerin reduces Rac-GTP levels by
residues of the SH2-C1 linker, residues 139–147 com- 25%, the mutants Q32A and I130A reduce Rac-GTP
levels by 40% and 80%, respectively (Figure 5).prise another helix (L for “linker”) resting on the C1
Cell
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Figure 1. Structure of 2-Chimaerin
(A) Refined model of 2-chimaerin in the vicinity of Gln32 superimposed on the solvent-modified single anomalous dispersion (SAD) Fourier syn-
thesis.
(B) Overall structure of 2-chimaerin. The domains red (SH2), blue (C1), green (RacGAP), and grey (linkers).
(C) Structure of the SH2 domain (red) overlaid on the SH2 domain of Src (cyan) and showing the internal phosphotyrosine-containing sequence
in Src in a stick representation.
(D) Structure of the C1 domain (blue) overlaid on the C1B domain of PKC (cyan) and showing phorbol ester as bound to the the PKC-C1B.
(E) Structure of the RacGAP domain (green) overlaid on the RhoGAP domain of p50RhoGAP (grey), showing the bound Cdc42 protein (yellow)
in complex with GDP and AlFx (stick model).
(F) Linker regions are shown in a worm represenation, with the rest of 2-chimaerin shown in a space-filling representation, oriented and
colored as in (B).
Discussion driven by diacylglycerol or phorbol ester binding to the
C1 domain, concomitant with C1 domain penetration
into the membrane. The crystal structure of the PKCMechanism of Membrane Translocation
The protein targets of diacylglycerol translocate from C1B domain in complex with phorbol ester showed that
exposed hydrophobic side chains ring the bound phor-the cytosol to membranes in response to diacylglycerol
signals or phorbol ester treatment. This translocation is bol ester but make limited or no direct contact with it
Lipid Activation of 2-Chimaerin
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Figure 2. Membrane Insertion and Phorbol
Ester Binding Sites on the C1 Domain
(A) Hydrophobic residues on the membrane-
inserting rim of the C1 domain. Residues that
are completely buried in intramolecular con-
tacts are colored yellow and residues that are
partially buried, white. The remainder of 2-
chimaerin is shown in a surface represen-
tation.
(B) The solvent-exposed environment of the
membrane-interacting basic residues (stick
model) of the C1 domain is shown.
(C) Docked model of phorbol ester (green)
bound to the 2-chimaerin C1 domain, with
hydrogen bonds indicated.
(D) The C1 domain and Gln32 from the N
helix are shown.
(Zhang et al., 1995). Five of these side chains are identi- ring surrounding the phorbol ester binding site inserts
into the membrane. The 12- and 13-positions of thecal or conserved throughout all phorbol ester binding
C1 domains (Hurley et al., 1997). In the PKC C1B do- phorbol ester, which are esterified to acyl groups that
are membrane bound, point in the same direction asmain, these are Pro231, Phe243, Leu250, Trp252, and
Leu254. There are two other prominent exposed hy- the hydrophobic side chains. Docking of a long chain
phorbol ester into the membrane requires that thesedrophobic side chains nearby on the PKCC1B domain,
Met239 and Val255, which are incompletely conserved side chains penetrate the membrane. These residues of
PKC are critical for phorbol ester binding when thein phorbol ester binding C1 domains. In 2-chimaerin,
the Met239 is replaced by Arg223, and the remaining ex- ligand is presented in micelles, as judged by the ablation
of binding in site-directed mutants at these positionsposed hydrophobic residues are conserved (Figure 2B).
Several lines of evidence show that the hydrophobic (Kazanietz et al., 1995b). The NMR structure of the C1B
domain of PKC determined in the presence of phorbol
ester and short chain phospholipid micelles (Xu et al.,
1997a) shows that the hydrophobic side chains interact
with the phospholipid micelles. Surface pressure analy-
sis of PKC shows that it penetrates membranes upon
diacylglycerol-induced membrane binding (Medkova
and Cho, 1999) and that mutations of the hydrophobic
side chains in the C1A domain of PKC block penetra-
tion (Medkova and Cho, 1999). The C1 domains of PKC,
, and , and 2-chimaerin are highly conserved (46%
identity between the PKCC1B and the 2-chimaerin C1
domain sequences). The membrane penetration studies
have been executed on closely related systems, and the
results are consistent with a common picture of the
translocation mechanism.
The burial of 40% of the C1 domain surface, and
almost all of its presumed membrane insertion site, is
a key observation in this study. The C1 domain surfaces
buried in these contacts overlap extensively with the
surfaces involved in phospholipid and phorbol ester
binding. Of the six hydrophobic side chains believed to
insert into the membrane, four are completely buried,
and two are partially buried in contacts with the rest of
the protein. The main chain NH and CO groups on Gly235Figure 3. Model of the 2-Chimaerin (green)/Rac (yellow) Complex
with GDP and AlFx are presumed to interact with the 3- and 4-hydroxyls
Cell
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Figure 4. 2-Chimaerin Translocation in Cells
(A) Residues targeted for mutational analysis. Domains of 2-chimaerin are colored as in Figure 1.
(B and C) COS-1 cells were transfected with pEGFP-2-chimaerin (wild-type), pEGFP-2-chimaerin-Q32A, or pEGFP-2-chimaerin-I130A.
Forty-eight hours later, cells were incubated with different concentrations of PMA for 20 min and subjected to subcellular fractionation.
Representative Western blots using an anti-GFP antibody or for endogenous PKC are shown in (B). Panel C shows a densitometric analysis
of the immunoreactivity in the soluble fraction. Results are expressed as percentage of the values observed in control (nontreated) cells and
represent the mean standard error of 4–7 independent experiments. The corresponding EC50 values are shown in the inset.
(D) EC50 values for all ten mutants constructed.
of phorbol ester, as seen for Gly253 of PKC-. In 2- interactions with specific regions within 2-chimaerin
inhibit membrane binding, and therefore phorbol ester-chimaerin, the amide group of the side chain of Gln32
replaces this interaction and sterically blocks the phor- induced translocation, ten single-site mutants were con-
structed in each of the four regions of 2-chimaerin thatbol ester binding site. This implies that the observed
conformation of2-chimaerin is incompatible with phor- interact with the C1 domain. Nine of the ten mutants
decrease the EC50 for phorbol ester-induced transloca-bol ester and phospholipid membrane binding. Four dif-
ferent regions of the protein contact the C1 domain: the tion, with the sensitization ranging from 15- to 90-fold.
The smallest enhancement, 15-fold, is seen in the Q32AN terminus, the SH2 domain, the SH2-C1 linker, and the
RacGAP domain. These four different regions converge mutant, which obliterates polar interactions, rather than
the hydrophobic interactions lost in other mutants. Theat the membrane insertion site on the C1 domain, and
each of the four is directly involved in contacts with the largest enhancements of phorbol ester sensitivity, 90-
fold, are seen in the mutants L28A and I130A. Leu28hydrophobic side chains.
The cost in free energy to break the extensive interac- buries itself against the junction between L and the C1
domain, while Ile130 is buried in the N/C1 interface.tions between the C1 domain and these four protein
regions must be considerable. This would lead to the Mutating residues that stabilize more than one interdo-
main contact thus produces the largest sensitivity en-prediction that intact 2-chimaerin would translocate
to membranes at higher doses of phorbol ester than hancements. One mutation, T126A, produces an effect
opposite to the rest, increasing the phorbol ester EC50required for the C1 domain alone or for proteins with
less buried C1 domains. Indeed, 2-chimaerin translo- by 4-fold. Thr126 has a 3.4 A˚ close contact with Leu236
of the C1 domain, and this contact appears to pushcation to cell membranes requires a dose 100-fold
higher than translocation of PKC (Caloca et al., 2001). Leu236 into a less favorable conformation than that ob-
served in the PKC-C1B structure. The T126A mutant1-chimaerin, the product of alternative splicing of the
same gene as 2-chimaerin, lacks the SH2 domain of may relieve intramolecular steric strain, thereby stabiliz-
ing the inactive conformation of 2-chimaerin.2-chimaerin and therefore has fewer intramolecular in-
teractions with the C1 domain. 1-chimaerin translo- We infer from this structure that the cooperative col-
lapse of all of these interactions is a prerequisite forcates to membranes at a much lower dose of phorbol
ester than 2-chimaerin, consistent with a greater de- membrane binding. In other words, membrane binding
by 2-chimaerin must be coupled to a massive confor-gree of solvent exposure of its C1 domain (Figure 4D).
In order to directly test the concept that intramolecular mational change involving the entire protein. We mod-
Lipid Activation of 2-Chimaerin
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Figure 5. RacGAP Activation in Cells
Rac-GTP levels were measured in COS-1
cells untransfected (control) or transfected
with plasmids encoding for GFP-2-chi-
maerin wild-type (wt), Q32A or I130A. After
transfection, cells were grown in full medium
for 48 hr.
(A) Representative experiment showing Rac-
GTP levels, total Rac levels, and the expres-
sion of the corresponding GFP-fusion pro-
teins.
(B) Densitometric analysis of Rac-GTP levels
normalized to total Rac levels in each case.
Values are expressed as % of control and
they represent the mean of seven indepen-
dent experiments SE. Differences between
groups are significant by t test with p 0.001,
except wt versus Q32A (p  0.036).
eled the structure of the active, membrane bound con- Second, the F helix appears to be locked in the unli-
ganded conformation (Figure 7B). The liganded confor-formation (Figure 6) based on the assumption that
hydrophobic surfaces liberated by the collapse of inter- mation of p50RhoGAP suggests the likely conformation
of the 2-chimaerin RacGAP domain in complex withdomain interactions would preferentially embed them-
selves in the surface of the membrane, rather than re- substrate. The liganded complex predicts a movement
of the helix by 6 A˚ in order to make contact with Rac.maining exposed to aqueous solvent.
This structural change would lead to carbon-carbon
contacts as close as 3.1 A˚ between Pro21 and Ser440Mechanism of Rac Recognition, Specificity,
of the F helix. Both of these inhibitory features couldand GTPase Activation
be relieved by a conformational change moving Pro21The 2-chimaerin structure, taken together with model-
and 22 out of their observed positions. However, theing of the 2-chimaerin/Rac transition state-like com-
diPro unit is structurally rigid, the local environment inplex, shows how 2-chimaerin could promote the
the Rac binding cleft is conformationally restrictive, andGTPase activity of Rac. Based on the model, Arg311 of
it is not apparent how such a structural change could2-chimaerin acts as the “arginine finger,” reaches into
occur without moving the residues that connect thethe active site of Rac, and directly stabilizes the transi-
diPro unit to the rest of 2-chimaerin. The next twotion state for GTP hydrolysis. The structure explains the
residues in sequence, Ile23 and Trp24, are wedged be-specificity of 2-chimaerin for Rac, as opposed to its
tween the C1 and RacGAP domain, and the N terminusclose relatives Rho and Cdc42. In a hypothetical 2-
is thereby anchored to both domains via extensive hy-chimaerin/Rho complex, unfavorable steric and electro-
drophobic interactions. It appears that these interac-static interactions would be formed between the Asp90
tions would need to be broken in order to free the diProand Glu97 of Rho and the Phe315 and Glu317 of 2-
motif to move out of the GAP active site. Indeed, mutantschimaerin. These interactions should be particularly dis-
that destabilize that inactive conformation are remark-ruptive to catalysis, given their proximity to the catalytic
ably potent as RacGAPs as they reduce Rac-GTP levelsArg311. Asp90 of RhoA has been shown to be a key
in cells growing in 10% serum (Figure 5) as well as indeterminant for GAP specificity (Li et al., 1997). These
response to EGF (H. Wang et al., unpublished).predicted unfavorable interactions are consistent with
the lack of RhoGAP activity in 2-chimaerin (Caloca et
al., 2003). The replacement of the two acidic residues Lipid Activation of 2-Chimaerin
Two central observations in this study allow us to pro-in Rho by two Ala residues in Rac negates these inhibi-
tory interactions. pose a mechanism for the acidic phospholipid-depen-
dent GAP activation of 2-chimaerin. First, the mem-The observed 2-chimaerin structure appears to be
inactive for catalysis in two respects. First, Pro21 and brane penetrating and phorbol ester binding sites on
2-chimaerin are occluded by intramolecular interac-Pro22 directly occlude the Rac binding site (Figure 7A).
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Figure 6. Membrane Interactions of 2-Chimaerin
(A) Model for membrane-docked, active 2-chimaerin, with domains colored as in Figure 1. The geranylgeranyl group is taken from the
structure of Rac (yellow) bound to its guanine nucleotide dissociation inhibitor.
(B) Molecular surface of inactive 2-chimaerin. Hydrophobic surface is colored green, basic blue, acidic red, and uncharged polar white.
(C) Molecular surface of the model of the active, membrane bound 2-chimaerin, colored as in (B) and view looking directly out of the membrane.
tions with four separate regions of the protein. As de- the interdomain interactions seen in the inactive state.
Second, the Rac binding site on 2-chimaerin is oc-scribed above, this implies that membrane engagement
leads to a very large conformational change collapsing cluded. Rac binding requires the removal of the N-ter-
Figure 7. Autoinhibition and Activation of the
RacGAP Domain
(A) Pro21 and Pro22 (yellow stick model) of
2-chimaerin, overlaid on the docked struc-
ture of Rac (translucent surface and model).
(B) The F helix in the observed conforma-
tion (green) and predicted active conforma-
tion (cyan and translucent), with the N-ter-
minal region in gray.
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minal region from the RacGAP domain active site. The appear to have diverged, with each C1 domain special-
ized for a unique purpose. The presence of a relativelyN-terminal segment is tightly anchored by the C1 and
RacGAP domains, and it participates directly in the oc- accessible C1 domain enhances sensitivity to low levels
of diacylglycerol, while the more buried C1 domain isclusion of the phospholipid binding site. We propose an
activation model in which acidic phospholipid mem- required for allosteric activation.
The activating conformational change in 2-chimaerinbranes compete with intramolecular interactions for
binding to the C1 domain (Figure 6A). When the former not only exposes the hydrophobic membrane binding
surface of the C1 domain, but it also exposes hydropho-bind, the latter interactions are disrupted. The disruption
of these intramolecular interactions allows the N termi- bic surfaces in the four other regions of 2-chimaerin
that were formerly wrapped around the C1 domain. Innus sufficient flexibility to leave the RacGAP active site,
removes steric inhibition of Rac binding, and permits the order to avoid exposing a large amount of hydrophobic
surface area to solvent, these regions must reassociateF helix to adopt the active conformation (Figure 7B).
with each other, or with the membrane. The latter seems
more likely, in that specific packing arrangements needImplications for PKC and Other
not be fulfilled. It has been shown that the pseudosub-C1 Domain Proteins
strate region of PKC is capable of binding to membranesMost biochemical investigation of phorbol ester and di-
(Mosior and McLaughlin, 1991), and the presence of thisacylglycerol-activated proteins has focused on the
region directly contributes to stabilizing the associationPKCs, which are ubiquitous in mammalian cell biology.
of PKC with cell membranes in vivo (Oancea and Meyer,Within the PKCs, the conventional isozymes (, I, II,
1998). By the same token, the hydrophobic faces of) have been the most thoroughly studied (Newton and
linker regions freed by an activating conformationalJohnson, 1998). Conventional PKCs (cPKCs) contain an
change in 2-chimaerin are also likely to stabilize mem-N-terminal pseudosubstrate region, two phorbol ester
brane association.and diacylglycerol binding C1 domains, a Ca2 binding
C2 domain, and a protein kinase catalytic domain (New-
Experimental Procedureston and Johnson, 1998). The novel PKCs (nPKCs; , ,
, ) are similar, except that they contain a C2 domain
Expression and Purification of 2-Chimaerinthat does not bind Ca2. The structures of PKC C1 and
2-chimaerin was expressed as a glutathione S-transferase (GST)
C2 domains have been determined, but no structure of fusion protein in Sf9 cells using a baculovirus vector (Caloca et al.,
an intact PKC is available (Hurley, 2003). The cPKCs are 1997). Sf9 cells were infected in roller bottles and grown on 245
potently activated in vitro and in vivo by phorbol esters mm nontreated square bioassay dishes (Corning). The plates were
incubated at 27
C for 72 hr. The cells were harvested by centrifuga-or diacylglycerol in the presence of phospholipids. Like
tion at 2000 rpm, washed with phosphate-buffered saline (PBS),2-chimaerin, L-phosphatidylserine is the preferred ac-
and frozen at 80
C. Cells were lysed by homogenization in 20 mMtivating lipid (Newton and Johnson, 1998).
Tris-HCl (pH 7.4), 100 mM NaCl, 1% (w/v) octylglucoside, 1 mM
Activating lipids produce a large conformational change PMSF, 2 mM DTT, 1 mM EDTA, 1 mM NaF, 1 mM benzamidine,
in cPKCs as judged by susceptibility to limited proteoly- 10 mM -glycerolphosphate, and 2 mM sodium pyrophosphate. The
sis (Orr et al., 1992). The N-terminal pseudosubstrate cell lysate was centrifuged at 100,000  g for 30 min at 4
C. The
supernatant was mixed with glutathione-sepharose 4B beadssequence functions as an autoinhibitory domain. The
(Amersham-Pharmacia). The GST-2-chimaerin fusion protein wasconformational change leads to the ejection of the N-ter-
cleaved by incubating the beads with thrombin at 4
C overnight.minal pseudosubstrate region from the active site of the
The cleaved 2-chimaerin was eluted in 20 mM Tris-HCl (pH 7.4),
catalytic domain and thence to enzyme activation (Orr 100 mM NaCl, 1 mM EDTA, 5 mM DTT, 1 mM benzamidine, and 1
and Newton, 1994). We now find from the present struc- mM PMSF. The protein was further purified with a phenyl sepharose
ture that 2-chimaerin, like the PKCs, has an N-terminal column (Amersham-Pharmacia) using a 2 M to 0 mM NaCl gradient.
The peak fractions were judged to be at least 99% pure by SDS-autoinhibitory region, albeit not one that has any rela-
PAGE. The protein was then concentrated to approximately 80tionship to the sequence of the substrate protein, Rac.
mg/ml, in 20 mM Tris-HCl (pH 7.4), 300 mM NaCl, 1 mM EDTA, 5The cPKCs and nPKCs contain two C1 domains, and
mM DTT, and 1 mM benzamidine, and stored at 4
C.
there is ample evidence that they have nonequivalent
roles. The reason for the evolution of tandem C1 do-
Crystallization and Data Collectionmains in PKCs has been a longstanding question. In
Crystals were obtained at 4
C using the hanging drop method by
PKC, the C1B domain is primarily responsible for trans- mixing 80 mg/ml protein in storage buffer with an equal volume of
location (Szallasi et al., 1996), implying that the C1A a reservoir solution containing 50 mM Na/K phosphate (pH 6.8) and
0.5%–1.0% ethanol (200 proof). Crystals appeared in 48 hr andmight be more buried. In PKC, both C1 domains are
typically reached dimensions of 1.0 mm  0.3 mm  0.3 mm in twothought to be exposed (Ananthanarayanan et al., 2003).
weeks. The crystals belong to the hexagonal space group P6122Conflicting reports suggest that in PKC (Bogi et al.,
with one molecule per asymmetric unit. Unit cell dimensions are1999), both C1 domains are equally important for trans-
a 	 b 	 131.09 A˚ and c 	 288.75 A˚. The solvent content of the
location, yet the C1A domain is more buried (Anantha- crystal is 81%. Before data collection, crystals were cryoprotected
narayanan et al., 2003). It is likely that the PKCs are in reservoir solution supplemented with glycerol (up to 45%). After
10 min of soaking, crystals were mounted on cryoloops (Hampton,translocated primarily by the more accessible of their
Riverside, California) and were frozen in liquid propane.two C1 domains. 2-chimaerin is a relatively inefficient
Xenon-derivatized crystals were prepared in an Xcell pressuretranslocator compared to the PKCs, and it is an example
chamber (Oxford Cryosystems) using a xenon pressure of 20 barof a buried C1 domain. 2-chimaerin might be consid-
for 3.5 min, after depressurization, crystals were immediately flash-
ered a primitive C1 domain in which both the activation frozen in propane (Soltis et al., 1997). The native data set was col-
and translocation functionalities reside in a single do- lected at the National Synchrotron Light Source (NSLS) X25 beam-
line using a charge-coupled device (CCD) detector at 95 K. Themain. In the more sophisticated PKCs, the functions
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derivative data set was collected at Advanced Proton Source (APS) acknowledge the use of synchrotron facilities at the NSLS beamline
SER-CAT beamline at the Zn edge in order to maximize native Zn X25, the APS SER-CAT and SBC-CAT beamlines, and the ALS.
anomalous scattering. Images were indexed and integrated with the M.G.K. acknowledges the support from NIH grant RO1-CA74197.
program DENZO, and data were scaled using SCALEPACK, HKL Use of the Advanced Photon Source was supported by the U.S.
Research (Otwinowski and Minor, 1997). Department of Energy, Basic Energy Sciences, Office of Science,
under Contract No.W-31-109-Eng-38.
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